Lucid Diagnostics Inc.

Lucid Diagnostics Inc.verified

LUCD

Price:

$0.999

Market Cap:

$53.94M

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its lead products include EsoGuard, a laboratory developed esophageal DNA test; and EsoCheck, an esophageal cell collection device. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.[Read more]

Industry

Medical - Devices

IPO Date

2021-10-14

Stock Exchange

NASDAQ

Ticker

LUCD

The Enterprise Value as of November 2024 (TTM) for Lucid Diagnostics Inc. (LUCD) is 52.51M

According to Lucid Diagnostics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 52.51M. This represents a change of 37.41% compared to the average of 38.22M of the last 4 quarters.

Lucid Diagnostics Inc. (LUCD) Historical Enterprise Value (quarterly & annually)

How has LUCD Enterprise Value performed in the past?

The mean historical Enterprise Value of Lucid Diagnostics Inc. over the last ten years is 253.77M. The current 52.51M Enterprise Value has changed 1.97% with respect to the historical average. Over the past ten years (40 quarters), LUCD's Enterprise Value was at its highest in in the September 2021 quarter at 22.40T. The Enterprise Value was at its lowest in in the March 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

253.77M

Median

284.36M

Minimum

28.72M

Maximum

435.01M

Lucid Diagnostics Inc. (LUCD) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Lucid Diagnostics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 92.33%

Maximum Annual Enterprise Value = 435.01M

Minimum Annual Increase = -78.54%

Minimum Annual Enterprise Value = 28.72M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202355.24M92.33%
202228.72M-78.54%
2021133.85M-69.22%
2020434.92M0.01%
2019434.87M-0.03%

Lucid Diagnostics Inc. (LUCD) Average Enterprise Value

How has LUCD Enterprise Value performed in the past?

The current Enterprise Value of Lucid Diagnostics Inc. (LUCD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

72.60M

5-year avg

217.52M

10-year avg

253.77M

Lucid Diagnostics Inc. (LUCD) Enterprise Value vs. Peers

How is LUCD’s Enterprise Value compared to its peers?

Lucid Diagnostics Inc.’s Enterprise Value is less than Inari Medical, Inc. (2.90B), greater than Beyond Air, Inc. (23.80M), greater than PAVmed Inc (45.23M), less than ClearPoint Neuro, Inc. (308.59M), greater than ProSomnus, Inc. Common Stock (40.81M), less than LivaNova PLC (3.12B), less than Electromed, Inc. (238.10M), less than OrthoPediatrics Corp. (611.40M), less than Surmodics, Inc. (554.56M), less than NeuroPace, Inc. (347.61M), less than Paragon 28, Inc. (910.24M), less than CVRx, Inc. (310.32M), less than Pulmonx Corporation (260.62M), less than IRadimed Corporation (623.15M), less than Orthofix Medical Inc. (829.81M), less than Integer Holdings Corporation (5.77B),

Build a custom stock screener for Lucid Diagnostics Inc. (LUCD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lucid Diagnostics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lucid Diagnostics Inc. (LUCD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lucid Diagnostics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Lucid Diagnostics Inc.'s Enterprise Value?

What is the highest Enterprise Value for Lucid Diagnostics Inc. (LUCD)?

What is the 3-year average Enterprise Value for Lucid Diagnostics Inc. (LUCD)?

What is the 5-year average Enterprise Value for Lucid Diagnostics Inc. (LUCD)?

How does the current Enterprise Value for Lucid Diagnostics Inc. (LUCD) compare to its historical average?